Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CD23/Fc epsilon RII Antibody (OTI2B6), Biotin, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP270701B

Catalog No. NBP270701B


Add to Cart

Description

Description

CD23/Fc epsilon RII Monoclonal specifically detects CD23/Fc epsilon RII in Human samples. It is validated for Western Blot, Immunohistochemistry.
Specifications

Specifications

CD23/Fc epsilon RII
Monoclonal
Biotin
PBS with 0.05% Sodium Azide
FCER2
Recombinant protein fragment corresponding to amino acids 48-321 of human CD23/Fc epsilon RII (NP_001993) produced in SF9 cell.
0.1 mL
Primary
Human
IgG1
Western Blot, Immunohistochemistry
OTI2B6
Western Blot, Immunohistochemistry
BLAST-2, CD23A, CD23CD23 antigen, CLEC4JC-type lectin domain family 4 member J, C-type lectin domain family 4, member J, Fc fragment of IgE, low affinity II, receptor for (CD23), FCE2Fc fragment of IgE, low affinity II, receptor for (CD23A), fc-epsilon-RII, IGEBF, Immunoglobulin E-binding factor, low affinity immunoglobulin epsilon Fc receptor, Lymphocyte IgE receptor
Mouse
Affinity Purified
Adaptive Immunity, B Cell Development and Differentiation Markers, Biologically Active Proteins, Cancer, Immunology, Phospho Specific
2208.0
Store at 4°C in the dark.
Product Suggestions

Product Suggestions

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit